The authors observed a highly significant reduction on total AIMS score by approximately 22%, as well as on individual AIMS items—including AIMS severity score—with amantadine but not with placebo (Pappa et al. 2010 ).
← all excerpts
Amantadine: reappraisal of the timeless diamond-target updates and novel therapeutic potentials.
1
—
—